RBC Life Sciences, Inc.

RBC Life Sciences, Inc. Action · US74926T2015 (OTC) — cotations en temps réel, données d'entreprise, dividendes, fondamentaux et analyse de portefeuille IA sur MoneyPeak

Aperçu
Analyse alimentée par l’IA
Analyse fondamentale
Découvrez ce que disent vraiment les chiffres — avant le marché
Analyser maintenant
Sentiment des actualités
Les actualités d’aujourd’hui sont-elles un signal d’achat ou un avertissement ?
Analyser maintenant
Acheter / Conserver / Vendre
Faut-il acheter, conserver ou vendre ? Obtenez l’avis de l’IA dès maintenant.
Analyser maintenant
Évaluation des risques
Détectez les risques cachés avant qu’ils n’impactent votre portefeuille.
Analyser maintenant
Juste valeur
Cette action est-elle bon marché, correctement valorisée ou surévaluée ?
Analyser maintenant
Dernières analyses d’IA sur RBC Life Sciences, Inc.
Pas de cours
Cours de clôture OTC 30.04.2026: 0,0007 USD
30.04.2026 20:00
Cours actuels de RBC Life Sciences, Inc.
BourseTickerDeviseDernier échangeCoursVariation journalière
OTC: UTC
UTC
RBCL
USD
30.04.2026 20:00
0,0007 USD
0,00 USD
Profil de l'entreprise pour RBC Life Sciences, Inc. Action
RBC Life Sciences, Inc. manufactures, markets, and distributes nutritional supplements and personal care products in North America, Southeast Asia, and Australia. The company's Nutritional Products segment offers nutritional supplements and personal care products, including herbs, vitamins, and minerals; and natural skin, hair, and body care products through a network of independent distributors and license arrangements. Its products include Stem-Kine, a dietary supplement; Microhydrin and Microhydrin Plus antioxidants; VitAloe, a blend of research-backed ingredients; OliViva, an antioxidant beverage to support immune and cardiovascular system; Organic Spirulina, a nutritious alga that provides range of nutrients and easily digested proteins; and NeuroBright to support brain function, and enhance energy and acuity. This segments products also comprise Colo-Vada Plus, a colon cleansing program; HydraCel to enhance the quality of drinking water; 24 Seven, a multivitamin/mineral supplement; Immune 360 to nourish and support the function of the immune system; and Aloe Gelee gel that provides the soothing and moisturizing. Its Medical Products segment offers wound care products for the treatment and healing of wounds, such as pressure ulcers, leg ulcers, cuts, burns, and abrasions. Its products include cleansers, dressings, hydrogels, collagen, calcium alginates, moisture barriers, antimicrobials, and a hydrogel wound dressing with Lidocaine. This segment also offers other wound care products designed to reduce destruction to skin and tissue caused by radiation; and to reduce pain and itching in the skin, and the internal mucosa caused by radiation reactions or reactions to various cancer medications. This segment sells its products under the MPM Medical brand to hospitals, nursing homes, clinics, and pharmacies through a network of medical/surgical supply dealers and pharmaceutical distributors. The company was founded in 1988 and is headquartered in Irving, Texas.

Données de l'entreprise

Nom RBC Life Sciences, Inc.
Société RBC Life Sciences, Inc.
Site web https://www.rbclifesciences.com
Marché d'origine OTC UTC
ISIN US74926T2015
Type de titre Action
Secteur Consumer Defensive
Industrie Household & Personal Products
PDG David Price
Pays États-Unis d'Amérique
Devise USD
Employés 0,1 T
Adresse 2301 Crown Court, 75038 Irving
Date d'introduction en bourse 2000-01-03

Fractionnements d'actions

Date Fractionnement
12.08.2013 1:10
17.04.1997 1:7

Symboles boursiers

Nom Symbole
Over The Counter RBCL
Autres actions
Les investisseurs qui détiennent RBC Life Sciences, Inc. ont également les actions suivantes dans leur portefeuille :
Federal Home Loan Mortgage Corporation
Federal Home Loan Mortgage Corporation Action
Metalliance S.A.
Metalliance S.A. Action